Stephen C Mitchell Selected Research

Carbocysteine (S-Carboxymethylcysteine)

4/2019	The S-oxidation of S-carboxymethyl-L-cysteine in hepatic cytosolic fractions from BTBR and phenylketonuria enu1 and enu2 mice.
1/2019	Drug S-oxidation and phenylalanine hydroxylase: a biomarker for neurodegenerative susceptibility in Parkinson's disease and amyotrophic lateral sclerosis.
9/2018	Phenylalanine hydroxylase: A biomarker of disease susceptibility in Parkinson's disease and Amyotrophic lateral sclerosis.
1/2016	Phenylalanine monooxygenase and the sulfur oxygenation of S-carboxymethyl-L-cysteine in mice.
2/2010	The pharmacokinetics of orally administered S-carboxymethyl-L-cysteine in the dog, calf and sheep.
10/2009	Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation.
11/2006	Carbocysteine therapy in older people with chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen C Mitchell Research Topics

Disease

5	Disease Susceptibility (Diathesis) 01/2019 - 01/2004
3	Phenylketonurias (Phenylketonuria) 04/2019 - 01/2009
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 09/2018
3	Parkinson Disease (Parkinson's Disease) 01/2019 - 09/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 02/2010 - 11/2006
1	Hypersensitivity (Allergy) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Confusion (Bewilderment) 02/2019
1	Dental Caries (Decay, Dental) 02/2019
1	Obstructive Lung Diseases (Obstructive Lung Disease) 02/2010
1	Body Weight (Weight, Body) 02/2010
1	Rheumatoid Arthritis 10/2009

Drug/Important Bio-Agent (IBA)

7	Carbocysteine (S-Carboxymethylcysteine)IBA 04/2019 - 11/2006
4	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2020 - 09/2018
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2009
2	EnzymesIBA 01/2020 - 01/2019
2	Phenylalanine (L-Phenylalanine)FDA Link 01/2020 - 01/2009
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2020
1	CarcinogensIBA 01/2020
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020
1	sapropterin (tetrahydrobiopterin)FDA Link 01/2020
1	Procainamide (Procan)FDA LinkGeneric 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	AcidsIBA 02/2019
1	OxidesIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	SulfurIBA 01/2016
1	Mutant Proteins (Protein, Mutant)IBA 01/2009
1	Sulfides (Thioethers)IBA 01/2004

Therapy/Procedure

2	Therapeutics 01/2020 - 11/2006
1	Dental Care 02/2019
1	Perinatal Care 02/2019
1	Oral Administration 02/2010